{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:13:44Z","timestamp":1791465224263,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tetraphase Pharmaceuticals","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]},{"name":"Becton, Dickinson and Company","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4387-3","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T13:02:49Z","timestamp":1566565369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013\u20132017"],"prefix":"10.1186","volume":"19","author":[{"given":"Vikas","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Olesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalvin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"4387_CR1","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. 2013. \n                    https:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf\n                    \n                  . Accessed 6 Aug 2018."},{"key":"4387_CR2","unstructured":"World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discover, and development of new antibiotics. 2017. \n                    http:\/\/apps.who.int\/medicinedocs\/documents\/s23171en\/s23171en.pdf\n                    \n                  . Accessed 6 Aug 2018."},{"key":"4387_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318\u201327.","journal-title":"Lancet Infect Dis"},{"key":"4387_CR4","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.clinthera.2016.04.035","volume":"38","author":"M Zalacain","year":"2016","unstructured":"Zalacain M, Biedenbach DJ, Badal RE, Young K, Motyl M, Sahm DE. Pathogen prevalence and antimicrobial susceptibility among Enterobacteriaceae causing hospital-associated intra-abdominal infections in adults in the United States (2012-2013). Clin Ther. 2016;38:1510\u201321.","journal-title":"Clin Ther"},{"key":"4387_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12879-017-2383-z","volume":"17","author":"MD Zilberberg","year":"2017","unstructured":"Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC Infect Dis. 2017;17:279.","journal-title":"BMC Infect Dis"},{"key":"4387_CR6","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1017\/ice.2016.174","volume":"37","author":"LM Weiner","year":"2016","unstructured":"Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011\u20132014. Infect Control Hosp Epidemiol. 2016;37:1288\u2013301.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4387_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jhm.2477","volume":"11","author":"MD Zilberberg","year":"2016","unstructured":"Zilberberg MD, Kollef MH, Shorr AF. Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: a survey study. J Hosp Med. 2016;11:21\u20136.","journal-title":"J Hosp Med"},{"key":"4387_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.15585\/mmwr.mm6713e1","volume":"67","author":"KR Woodworth","year":"2018","unstructured":"Woodworth KR, Walters MS, Weiner LM, Edwards J, Brown AC, Huang JY, et al. Vital signs: containment of novel multidrug-resistant organisms and resistance mechanisms \u2013 United States, 2006-2017. MMWR Morb Mortal Wkly Rep. 2018;67:396\u2013401.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4387_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1309\/502AUPR8VE67MBDE","volume":"125","author":"SE Brossette","year":"2006","unstructured":"Brossette SE, Hacek DM, Gavin PJ, Kamdar MA, Gadbois KD, Fisher AG, et al. A laboratory-based, hospital-wide, electronic marker for nosocomial infection: the future of infection control surveillance? Am J Clin Pathol. 2006;125:34\u20139.","journal-title":"Am J Clin Pathol"},{"key":"4387_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ajic.2015.12.044","volume":"44","author":"JP Ridgway","year":"2016","unstructured":"Ridgway JP, Sun X, Tabak YP, Johannes RS, Robicsek A. Performance characteristics and associated outcomes for an automated surveillance tool for bloodstream infection. Am J Infect Control. 2016;44:567\u201371.","journal-title":"Am J Infect Control"},{"key":"4387_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1086\/670621","volume":"34","author":"YP Tabak","year":"2013","unstructured":"Tabak YP, Zilberberg MD, Johannes RS, Sun X, McDonald LC. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol. 2013;34:588\u201396.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4387_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijid.2019.06.017","volume":"85","author":"V Gupta","year":"2019","unstructured":"Gupta V, Ye G, Olesky M, Lawrence K, Murray J, Yu K. National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States. Int J Infect Dis. 2019;85:203\u201311.","journal-title":"Int J Infect Dis"},{"key":"4387_CR13","doi-asserted-by":"publisher","first-page":"ofy241","DOI":"10.1093\/ofid\/ofy241","volume":"5","author":"E McCann","year":"2018","unstructured":"McCann E, Srinivasan A, DeRyke CA, DePestel DD, Murray J, Gupta V. Carbapenem-nonsusceptible Gram-negative pathogens in ICU and non-ICU settings in US hospitals in 2017: a multicenter study. Open Forum Infect Dis. 2018;5:ofy241.","journal-title":"Open Forum Infect Dis"},{"key":"4387_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"4387_CR15","unstructured":"Centers for Disease Control and Prevention. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). 2015. \n                    https:\/\/www.cdc.gov\/hai\/pdfs\/cre\/CRE-guidance-508.pdf\n                    \n                  . Accessed 8 Aug 2018."},{"key":"4387_CR16","unstructured":"Centers for Disease Control and Prevention. Antimicrobial use and resistance (AUR). 2018. \n                    https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/11pscaurcurrent.pdf\n                    \n                  . Accessed 6 Aug 2018."},{"key":"4387_CR17","unstructured":"Centers for Disease Control and Prevention. Multidrug-resistant organisms and Clostridium difficile infection (MDRO\/CDI) module. 2018. \n                    https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/12pscmdro_cdadcurrent.pdf\n                    \n                  . Accessed 6 Aug 2018."},{"key":"4387_CR18","volume-title":"Forecasting, structural time series models and the Kalman filter","author":"AC Harvey","year":"1989","unstructured":"Harvey AC. Forecasting, structural time series models and the Kalman filter. Cambridge: Cambridge University Press; 1989."},{"key":"4387_CR19","first-page":"103","volume-title":"Advances in econometrics: messy data\u2014missing observations, outliers, and mixed-frequency data","author":"A Harvey","year":"2015","unstructured":"Harvey A, Koopman SJ. Messy time series: a unified approach. In: Fomby TB, Hill RC, editors. Advances in econometrics: messy data\u2014missing observations, outliers, and mixed-frequency data, vol. 13. Bingley: Emerald Group Publishing Limited; 2015. p. 103\u201343."},{"key":"4387_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cmi.2016.09.003","volume":"23","author":"SM Bartsch","year":"2017","unstructured":"Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, et al. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect. 2017;23:48\u2013e9\u201348-e.16.","journal-title":"Clin Microbiol Infect"},{"key":"4387_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/1469-0691.12363","volume":"20","author":"EV Lemos","year":"2014","unstructured":"Lemos EV, de la Hoz FG, Einarson TR, McGhan WF, Quevedo E, Castaneda C, et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect. 2014;20:416\u201323.","journal-title":"Clin Microbiol Infect"},{"key":"4387_CR22","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1017\/ice.2017.156","volume":"38","author":"J McDanel","year":"2017","unstructured":"McDanel J, Schweizer M, Crabb V, Nelson R, Samore M, Khader K, et al. Incidence of extended-spectrum \u03b2-lactamases (ESBL)-producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review. Infect Control Hosp Epidemiol. 2017;38:1209\u201315.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4387_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1017\/ice.2015.239","volume":"37","author":"JT Thaden","year":"2016","unstructured":"Thaden JT, Fowler VG, Sexton DJ, Anderson DJ. Increasing incidence of extended-spectrum \u03b2-lactamase-producing Escherichia coli in community hospitals throughout the southeastern United States. Infect Control Hosp Epidemiol. 2016;37:49\u201354.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4387_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1089\/sur.2014.060","volume":"16","author":"MA Hackel","year":"2015","unstructured":"Hackel MA, Badal RE, Bouchillon SK, Biedenbach DJ, Hoban DJ. Resistance rates of intra-abdominal isolates from intensive care units and non-intensive care units in the United States: The Study for Monitoring Antimicrobial Resistance Trends 2010\u20132012. Surg Infect (Larchmt). 2015;16:298\u2013304.","journal-title":"Surg Infect (Larchmt)"},{"key":"4387_CR25","unstructured":"Food and Drug Administration. National Antimicrobial Resistance Monitoring System 2014 Trend Analysis 2014. \n                    https:\/\/www.fda.gov\/downloads\/AnimalVeterinary\/SafetyHealth\/AntimicrobialResistance\/NationalAntimicrobialResistanceMonitoringSystem\/UCM529799.pdf\n                    \n                  . Accessed 4 Sept 2018."},{"key":"4387_CR26","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1017\/ice.2018.52","volume":"39","author":"DL Russell","year":"2018","unstructured":"Russell DL, Uslan DZ, Rubin ZA, Grogan TR, Martin EM. Multidrug resistant Acinetobacter baumannii: a 15-year trend analysis. Infect Control Hosp Epidemiol. 2018;39:608\u201311.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4387_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1086\/592698","volume":"29","author":"EN Perencevich","year":"2008","unstructured":"Perencevich EN, McGregor JC, Shardell M, Furuno JP, Harris AD, Morris JG Jr, et al. Summer peaks in the incidences of gram-negative bacterial infection among hospitalized patients. Infect Control Hosp Epidemiol. 2008;29:1124\u201331.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4387_CR28","doi-asserted-by":"publisher","first-page":"e25298","DOI":"10.1371\/journal.pone.0025298","volume":"6","author":"MR Eber","year":"2011","unstructured":"Eber MR, Shardell M, Schweizer ML, Laxminarayan R, Perencevich EN. Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients. PLoS One. 2011;6:e25298.","journal-title":"PLoS One"},{"key":"4387_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/cid\/cis509","volume":"55","author":"L Sun","year":"2012","unstructured":"Sun L, Klein EY, Laxminarayan R. Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clin Infect Dis. 2012;55:687\u201394.","journal-title":"Clin Infect Dis"},{"key":"4387_CR30","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1017\/ice.2018.153","volume":"39","author":"A Shugart","year":"2018","unstructured":"Shugart A, Walters MS, Weiner LM, Lonsway D, Kallen AJ. Hospital microbiology laboratory practices for Enterobacteriaceae: Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN) annual survey, 2015 and 2016. Infect Control Hosp Epidemiol. 2018;39:1115\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4387_CR31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1086\/677157","volume":"35","author":"JT Thaden","year":"2014","unstructured":"Thaden JT, Lewis SS, Hazen KC, Huslage K, Fowler VG Jr, et al. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol. 2014;35:987\u20133.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4387_CR32","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1128\/JCM.06131-11","volume":"50","author":"A Birgy","year":"2012","unstructured":"Birgy A, Bidet P, Genel N, Doit C, Decr\u00e9 D, Arlet G, et al. Phenotypic screening of carbapenemases and associated \u03b2-lactamases in carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2012;50:1295\u2013302.","journal-title":"J Clin Microbiol"},{"key":"4387_CR33","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1056\/NEJMra0904124","volume":"362","author":"AY Peleg","year":"2010","unstructured":"Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med. 2010;362:1804\u201313.","journal-title":"N Engl J Med"},{"key":"4387_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1086\/502360","volume":"25","author":"M Eveillard","year":"2004","unstructured":"Eveillard M, Martin Y, Hidir N, Boussougant Y, Joly-Guilou ML. Carriage of methicillin-resistant Staphylococcus aureus among hospital employees: prevalence, duration, and transmission to households. Infect Control Hosp Epidemiol. 2004;25:114\u201320.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4387_CR35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/cid\/ciu943","volume":"60","author":"L Miller","year":"2015","unstructured":"Miller L, Eells SJ, David MZ, Ortiz N, Taylor AR, Kumar N, et al. Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors. Clin Infect Dis. 2015;60:753\u201363.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4387-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4387-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4387-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T23:06:19Z","timestamp":1598051179000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4387-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4387"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4387-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,23]]},"assertion":[{"value":"10 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Outcome studies using this retrospective, deidentified dataset were approved and informed consent was waived by the New England Institutional Review Board (Wellesley, Massachusetts).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"VG, GY, JM, and KY are employees of Becton, Dickinson & Company, Franklin Lakes, New Jersey. MO and KL are employees of Tetraphase Pharmaceuticals, Watertown, Massachusetts.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"742"}}